MIPHARM SPA
Marina Garlati has held various roles in the pharmaceutical industry, starting as Business Development at Schering Pharmaceuticals from April 1991 to January 1997. Marina then moved on to work as Assistant General Manager at ESSEX ITALIA SRL from February 1997 to June 1999, and later as Assistant Vice President at DADE BEHRING from July 1999 to May 2001. Currently, Marina is employed at Mipharm S.p.A. where Marina has worked since June 2001, holding various positions such as QA Assistant, Human Resources Assistant, Assistant Regulatory and Business Development, and Assistant President.
This person is not in any teams
MIPHARM SPA
Mipharm S.p.A. was born in January 1998 following the merger of Sandoz and Ciba Geigy, from which resulted the new company Novartis. Mipharm was founded by a group of ex managers coming from Novartis by mean of a spin-off of the manufacturing site located in Milan, Via Quaranta, previously owned by Sandoz. In December 2016, Mandarin Capital Partners II acquired the majority stake in Mipharm share capital. Today, Mipharm is one of the most valuable third party manufacturing and new product development sites in Italy and it claims to have four FDA approvals (Nasal Spray Solution, Oral Potent Drug, Sachet, Packaging). Mipharm has been investing significant resources to continuously improve manufacturing site qualitative standard and currently it is able to produce and to pack a huge range of products and pharmaceutical forms.